Targeting cancer metabolism: a therapeutic window opens
Related Experiment Video
Updated: May 29, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
1Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. mvh@mit.edu
Abstract:
Genetic events in cancer activate signalling pathways that alter cell metabolism. Clinical evidence has linked cell metabolism with cancer outcomes. Together, these observations have raised interest in targeting metabolic enzymes for cancer therapy, but they have also raised concerns that these therapies would have unacceptable effects on normal cells. However, some of the first cancer therapies that were developed target the specific metabolic needs of cancer cells and remain effective agents in the clinic today. Research into how changes in cell metabolism promote tumour growth has accelerated in recent years. This has refocused efforts to target metabolic dependencies of cancer cells as a selective anticancer strategy.
Insights
Targeting cancer cell metabolism offers a selective anticancer strategy. Research shows that exploiting cancer
Area of Science:
- Oncology and Cancer Biology
- Cellular Metabolism Research
Background:
- Cancer cells exhibit altered signaling pathways and metabolism.
- Clinical outcomes correlate with cell metabolism.
- Targeting metabolic enzymes presents therapeutic opportunities and challenges.
Purpose of the Study:
- To investigate targeting metabolic dependencies in cancer cells.
- To explore selective anticancer strategies based on altered cell metabolism.
Main Methods:
- Review of clinical evidence linking cell metabolism and cancer outcomes.
- Analysis of research on metabolic changes promoting tumor growth.
Main Results:
- Early cancer therapies targeting cell metabolism remain effective.
- Recent research accelerates understanding of metabolic reprogramming in tumors.
Conclusions:
- Targeting cancer's specific metabolic needs is a viable and selective anticancer strategy.
- Further research into metabolic dependencies can refine therapeutic approaches.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...